<DOC>
	<DOCNO>NCT01963195</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety dose escalation Icotinib advance non small cell lung cancer ( NSCLC ) patient therapy Icotinib , Iressa Tarceva .</brief_summary>
	<brief_title>Evaluation High Dose Icotinib Advanced Lung Cancer Patients After Failure Target Therapy</brief_title>
	<detailed_description>- 1 : evaluate efficacy correlation tyrosine kinase inhibitor ( TKI ) drug high-dose Icotonib group advance NSCLC patient high -dose Icotinib go routine TKI therapy - 2 evaluate efficacy correlation different high-dose group advance NSCLC patient high -dose Icotinib go routine TKI therapy</detailed_description>
	<criteria>1 . NSCLC patient confirm histology cytology 2 . The time interval must 4 week previous chemotherapy registration participate experiment receive chemotherapy , also toxicity recover . 3. least one measureable lesion accord RECIST 1.1 criterion lesion accept radiotherapy . 1 least one measureable lesion .if one measureable lesion , biological nature must confirm cytology histology . 2 single diameter lesion could measure least one follow method : Chest abdominal compute tomography ( CT ) magnetic resonance imaging ( MRI ) , conventional method diameter least 20mm diameter spiral CT OR least 10mm . 4 . ECOG 02 score 5. least 12 week expect survival time 6 . Women childbearing age must pregnancy test 7 day treatment result negative , men childbearing age : surgical sterilization treatment end three month take contraceptive measure 7. understand sign write informed consent voluntarily . If subject meet follow exclusion criterion , eligible participate study , 1 . Before enrollment trial use Erbitux , Herceptin carry anticancer therapy . 2. use phenytoin , carbamazepine , rifampicin , phenobarbital St. John 's Wort take trial 3. severe allergy Icotinib</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Adverse Reaction Drug</keyword>
	<keyword>Self Efficacy</keyword>
</DOC>